NEXGEL, Inc.
NEXGEL, Inc. NXGLW Peers
See (NXGLW) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NXGLW | $0.25 | -3.77% | 25.2M | -0.18 | -$1.39 | N/A |
| ISRG | $557.08 | -0.18% | 199.7B | 81.80 | $6.81 | N/A |
| BDX | $173.40 | +1.39% | 49.7B | 33.67 | $5.15 | +2.30% |
| BDXA | $59.24 | -2.24% | 49.1B | 21.44 | $2.76 | +2.30% |
| ALC | $87.81 | +1.01% | 43.4B | 38.51 | $2.28 | +0.38% |
| RMD | $252.27 | +1.03% | 37B | 28.28 | $8.92 | +0.84% |
| WST | $224.62 | +2.76% | 16.1B | 35.32 | $6.36 | +0.37% |
| BAX | $30.25 | +0.33% | 15.5B | -58.16 | -$0.52 | +2.66% |
| COO | $72.33 | +1.62% | 14.4B | 34.94 | $2.07 | N/A |
| HOLX | $64.33 | +1.99% | 14.3B | 27.03 | $2.38 | N/A |
Stock Comparison
NXGLW vs ISRG Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ISRG has a market cap of 199.7B. Regarding current trading prices, NXGLW is priced at $0.25, while ISRG trades at $557.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ISRG's P/E ratio is 81.80. In terms of profitability, NXGLW's ROE is -0.63%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, NXGLW is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BDX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, BDX has a market cap of 49.7B. Regarding current trading prices, NXGLW is priced at $0.25, while BDX trades at $173.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas BDX's P/E ratio is 33.67. In terms of profitability, NXGLW's ROE is -0.63%, compared to BDX's ROE of +0.06%. Regarding short-term risk, NXGLW is more volatile compared to BDX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BDXA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, BDXA has a market cap of 49.1B. Regarding current trading prices, NXGLW is priced at $0.25, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas BDXA's P/E ratio is 21.44. In terms of profitability, NXGLW's ROE is -0.63%, compared to BDXA's ROE of +0.06%. Regarding short-term risk, NXGLW is more volatile compared to BDXA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ALC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ALC has a market cap of 43.4B. Regarding current trading prices, NXGLW is priced at $0.25, while ALC trades at $87.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ALC's P/E ratio is 38.51. In terms of profitability, NXGLW's ROE is -0.63%, compared to ALC's ROE of +0.07%. Regarding short-term risk, NXGLW is more volatile compared to ALC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs RMD Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, RMD has a market cap of 37B. Regarding current trading prices, NXGLW is priced at $0.25, while RMD trades at $252.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas RMD's P/E ratio is 28.28. In terms of profitability, NXGLW's ROE is -0.63%, compared to RMD's ROE of +0.25%. Regarding short-term risk, NXGLW is more volatile compared to RMD. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs WST Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, WST has a market cap of 16.1B. Regarding current trading prices, NXGLW is priced at $0.25, while WST trades at $224.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas WST's P/E ratio is 35.32. In terms of profitability, NXGLW's ROE is -0.63%, compared to WST's ROE of +0.17%. Regarding short-term risk, NXGLW is more volatile compared to WST. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BAX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, BAX has a market cap of 15.5B. Regarding current trading prices, NXGLW is priced at $0.25, while BAX trades at $30.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas BAX's P/E ratio is -58.16. In terms of profitability, NXGLW's ROE is -0.63%, compared to BAX's ROE of -0.08%. Regarding short-term risk, NXGLW is more volatile compared to BAX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs COO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, COO has a market cap of 14.4B. Regarding current trading prices, NXGLW is priced at $0.25, while COO trades at $72.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas COO's P/E ratio is 34.94. In terms of profitability, NXGLW's ROE is -0.63%, compared to COO's ROE of +0.05%. Regarding short-term risk, NXGLW is more volatile compared to COO. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs HOLX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, HOLX has a market cap of 14.3B. Regarding current trading prices, NXGLW is priced at $0.25, while HOLX trades at $64.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas HOLX's P/E ratio is 27.03. In terms of profitability, NXGLW's ROE is -0.63%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, NXGLW is more volatile compared to HOLX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BDXB Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, NXGLW is priced at $0.25, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas BDXB's P/E ratio is 7.60. In terms of profitability, NXGLW's ROE is -0.63%, compared to BDXB's ROE of +0.06%. Regarding short-term risk, NXGLW is more volatile compared to BDXB. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ATR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ATR has a market cap of 10.1B. Regarding current trading prices, NXGLW is priced at $0.25, while ATR trades at $153.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ATR's P/E ratio is 28.03. In terms of profitability, NXGLW's ROE is -0.63%, compared to ATR's ROE of +0.15%. Regarding short-term risk, NXGLW is more volatile compared to ATR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MASI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, MASI has a market cap of 9.3B. Regarding current trading prices, NXGLW is priced at $0.25, while MASI trades at $171.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas MASI's P/E ratio is -31.44. In terms of profitability, NXGLW's ROE is -0.63%, compared to MASI's ROE of -0.41%. Regarding short-term risk, NXGLW is more volatile compared to MASI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs RGEN Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, RGEN has a market cap of 7.2B. Regarding current trading prices, NXGLW is priced at $0.25, while RGEN trades at $128.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas RGEN's P/E ratio is -305.48. In terms of profitability, NXGLW's ROE is -0.63%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, NXGLW is more volatile compared to RGEN. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs STVN Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, STVN has a market cap of 6.5B. Regarding current trading prices, NXGLW is priced at $0.25, while STVN trades at $23.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas STVN's P/E ratio is 45.88. In terms of profitability, NXGLW's ROE is -0.63%, compared to STVN's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to STVN. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MMSI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, MMSI has a market cap of 5.6B. Regarding current trading prices, NXGLW is priced at $0.25, while MMSI trades at $95.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas MMSI's P/E ratio is 46.71. In terms of profitability, NXGLW's ROE is -0.63%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to MMSI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs TFX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, TFX has a market cap of 5.4B. Regarding current trading prices, NXGLW is priced at $0.25, while TFX trades at $122.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas TFX's P/E ratio is 38.02. In terms of profitability, NXGLW's ROE is -0.63%, compared to TFX's ROE of +0.03%. Regarding short-term risk, NXGLW is more volatile compared to TFX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BLCO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, BLCO has a market cap of 4.1B. Regarding current trading prices, NXGLW is priced at $0.25, while BLCO trades at $11.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas BLCO's P/E ratio is -11.46. In terms of profitability, NXGLW's ROE is -0.63%, compared to BLCO's ROE of -0.08%. Regarding short-term risk, NXGLW is more volatile compared to BLCO. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs HAE Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, HAE has a market cap of 3.4B. Regarding current trading prices, NXGLW is priced at $0.25, while HAE trades at $70.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas HAE's P/E ratio is 21.30. In terms of profitability, NXGLW's ROE is -0.63%, compared to HAE's ROE of +0.18%. Regarding short-term risk, NXGLW is more volatile compared to HAE. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ICUI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ICUI has a market cap of 3.3B. Regarding current trading prices, NXGLW is priced at $0.25, while ICUI trades at $133.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ICUI's P/E ratio is -34.84. In terms of profitability, NXGLW's ROE is -0.63%, compared to ICUI's ROE of -0.05%. Regarding short-term risk, NXGLW is more volatile compared to ICUI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs XRAY Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, XRAY has a market cap of 3.2B. Regarding current trading prices, NXGLW is priced at $0.25, while XRAY trades at $15.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas XRAY's P/E ratio is -3.57. In terms of profitability, NXGLW's ROE is -0.63%, compared to XRAY's ROE of -0.38%. Regarding short-term risk, NXGLW is more volatile compared to XRAY. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs WRBY Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, WRBY has a market cap of 2.6B. Regarding current trading prices, NXGLW is priced at $0.25, while WRBY trades at $21.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas WRBY's P/E ratio is -179.92. In terms of profitability, NXGLW's ROE is -0.63%, compared to WRBY's ROE of -0.04%. Regarding short-term risk, NXGLW is more volatile compared to WRBY. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs QDEL Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, QDEL has a market cap of 2B. Regarding current trading prices, NXGLW is priced at $0.25, while QDEL trades at $29.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas QDEL's P/E ratio is -5.65. In terms of profitability, NXGLW's ROE is -0.63%, compared to QDEL's ROE of -0.11%. Regarding short-term risk, NXGLW is more volatile compared to QDEL. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs LMAT Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, NXGLW is priced at $0.25, while LMAT trades at $84.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas LMAT's P/E ratio is 42.65. In terms of profitability, NXGLW's ROE is -0.63%, compared to LMAT's ROE of +0.14%. Regarding short-term risk, NXGLW is more volatile compared to LMAT. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NVCR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, NXGLW is priced at $0.25, while NVCR trades at $16.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas NVCR's P/E ratio is -11.48. In terms of profitability, NXGLW's ROE is -0.63%, compared to NVCR's ROE of -0.45%. Regarding short-term risk, NXGLW is more volatile compared to NVCR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ATRC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ATRC has a market cap of 1.7B. Regarding current trading prices, NXGLW is priced at $0.25, while ATRC trades at $34.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ATRC's P/E ratio is -43.14. In terms of profitability, NXGLW's ROE is -0.63%, compared to ATRC's ROE of -0.08%. Regarding short-term risk, NXGLW is more volatile compared to ATRC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs AZTA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, AZTA has a market cap of 1.3B. Regarding current trading prices, NXGLW is priced at $0.25, while AZTA trades at $28.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas AZTA's P/E ratio is -8.79. In terms of profitability, NXGLW's ROE is -0.63%, compared to AZTA's ROE of -0.04%. Regarding short-term risk, NXGLW is more volatile compared to AZTA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs PLSE Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, PLSE has a market cap of 1.2B. Regarding current trading prices, NXGLW is priced at $0.25, while PLSE trades at $17.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas PLSE's P/E ratio is -17.27. In terms of profitability, NXGLW's ROE is -0.63%, compared to PLSE's ROE of -0.71%. Regarding short-term risk, NXGLW is more volatile compared to PLSE. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs BLFS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, BLFS has a market cap of 1.1B. Regarding current trading prices, NXGLW is priced at $0.25, while BLFS trades at $23.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas BLFS's P/E ratio is -124.89. In terms of profitability, NXGLW's ROE is -0.63%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, NXGLW is less volatile compared to BLFS. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs KMTS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, KMTS has a market cap of 1.1B. Regarding current trading prices, NXGLW is priced at $0.25, while KMTS trades at $20.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas KMTS's P/E ratio is -10.78. In terms of profitability, NXGLW's ROE is -0.63%, compared to KMTS's ROE of +0.27%. Regarding short-term risk, NXGLW is more volatile compared to KMTS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs STAA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, STAA has a market cap of 885M. Regarding current trading prices, NXGLW is priced at $0.25, while STAA trades at $17.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas STAA's P/E ratio is -12.41. In terms of profitability, NXGLW's ROE is -0.63%, compared to STAA's ROE of -0.18%. Regarding short-term risk, NXGLW is more volatile compared to STAA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ATRI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, NXGLW is priced at $0.25, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ATRI's P/E ratio is 64.50. In terms of profitability, NXGLW's ROE is -0.63%, compared to ATRI's ROE of +0.04%. Regarding short-term risk, NXGLW is more volatile compared to ATRI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ANGO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ANGO has a market cap of 449.1M. Regarding current trading prices, NXGLW is priced at $0.25, while ANGO trades at $11.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ANGO's P/E ratio is -10.95. In terms of profitability, NXGLW's ROE is -0.63%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, NXGLW is less volatile compared to ANGO. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NNNN Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, NNNN has a market cap of 362.1M. Regarding current trading prices, NXGLW is priced at $0.25, while NNNN trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas NNNN's P/E ratio is 137.50. In terms of profitability, NXGLW's ROE is -0.63%, compared to NNNN's ROE of +0.14%. Regarding short-term risk, NXGLW is more volatile compared to NNNN. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NYXH Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, NYXH has a market cap of 287.1M. Regarding current trading prices, NXGLW is priced at $0.25, while NYXH trades at $7.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas NYXH's P/E ratio is -3.36. In terms of profitability, NXGLW's ROE is -0.63%, compared to NYXH's ROE of -0.56%. Regarding short-term risk, NXGLW is more volatile compared to NYXH. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs SMTI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, SMTI has a market cap of 260.4M. Regarding current trading prices, NXGLW is priced at $0.25, while SMTI trades at $29.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas SMTI's P/E ratio is -21.87. In terms of profitability, NXGLW's ROE is -0.63%, compared to SMTI's ROE of -0.29%. Regarding short-term risk, NXGLW is more volatile compared to SMTI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs OSUR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, OSUR has a market cap of 216.2M. Regarding current trading prices, NXGLW is priced at $0.25, while OSUR trades at $2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas OSUR's P/E ratio is -6.88. In terms of profitability, NXGLW's ROE is -0.63%, compared to OSUR's ROE of -0.08%. Regarding short-term risk, NXGLW is more volatile compared to OSUR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs STXS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, STXS has a market cap of 191.8M. Regarding current trading prices, NXGLW is priced at $0.25, while STXS trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas STXS's P/E ratio is -7.19. In terms of profitability, NXGLW's ROE is -0.63%, compared to STXS's ROE of -2.17%. Regarding short-term risk, NXGLW is more volatile compared to STXS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs UTMD Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, UTMD has a market cap of 182.4M. Regarding current trading prices, NXGLW is priced at $0.25, while UTMD trades at $56.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas UTMD's P/E ratio is 14.78. In terms of profitability, NXGLW's ROE is -0.63%, compared to UTMD's ROE of +0.11%. Regarding short-term risk, NXGLW is more volatile compared to UTMD. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ZTEK Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ZTEK has a market cap of 152.3M. Regarding current trading prices, NXGLW is priced at $0.25, while ZTEK trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ZTEK's P/E ratio is -18.25. In terms of profitability, NXGLW's ROE is -0.63%, compared to ZTEK's ROE of -0.58%. Regarding short-term risk, NXGLW is more volatile compared to ZTEK. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs KRMD Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, KRMD has a market cap of 142.1M. Regarding current trading prices, NXGLW is priced at $0.25, while KRMD trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas KRMD's P/E ratio is -25.67. In terms of profitability, NXGLW's ROE is -0.63%, compared to KRMD's ROE of -0.30%. Regarding short-term risk, NXGLW is more volatile compared to KRMD. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs PDEX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, PDEX has a market cap of 139.9M. Regarding current trading prices, NXGLW is priced at $0.25, while PDEX trades at $42.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas PDEX's P/E ratio is 15.55. In terms of profitability, NXGLW's ROE is -0.63%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, NXGLW is less volatile compared to PDEX. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs INFU Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, INFU has a market cap of 128.2M. Regarding current trading prices, NXGLW is priced at $0.25, while INFU trades at $6.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas INFU's P/E ratio is 40.73. In terms of profitability, NXGLW's ROE is -0.63%, compared to INFU's ROE of +0.08%. Regarding short-term risk, NXGLW is more volatile compared to INFU. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ZJYL Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ZJYL has a market cap of 120.5M. Regarding current trading prices, NXGLW is priced at $0.25, while ZJYL trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ZJYL's P/E ratio is 38.49. In terms of profitability, NXGLW's ROE is -0.63%, compared to ZJYL's ROE of +0.13%. Regarding short-term risk, NXGLW is less volatile compared to ZJYL. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MBOT Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, MBOT has a market cap of 102.2M. Regarding current trading prices, NXGLW is priced at $0.25, while MBOT trades at $2.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas MBOT's P/E ratio is -4.53. In terms of profitability, NXGLW's ROE is -0.63%, compared to MBOT's ROE of -0.85%. Regarding short-term risk, NXGLW is more volatile compared to MBOT. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MLSS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, MLSS has a market cap of 71.7M. Regarding current trading prices, NXGLW is priced at $0.25, while MLSS trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas MLSS's P/E ratio is -15.22. In terms of profitability, NXGLW's ROE is -0.63%, compared to MLSS's ROE of -0.83%. Regarding short-term risk, NXGLW is more volatile compared to MLSS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs AKYA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, AKYA has a market cap of 57.4M. Regarding current trading prices, NXGLW is priced at $0.25, while AKYA trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas AKYA's P/E ratio is -1.20. In terms of profitability, NXGLW's ROE is -0.63%, compared to AKYA's ROE of -5.06%. Regarding short-term risk, NXGLW is more volatile compared to AKYA. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs OMIC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, NXGLW is priced at $0.25, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas OMIC's P/E ratio is -0.58. In terms of profitability, NXGLW's ROE is -0.63%, compared to OMIC's ROE of -0.58%. Regarding short-term risk, NXGLW is more volatile compared to OMIC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs IGAP Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, NXGLW is priced at $0.25, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas IGAP's P/E ratio is -10.52. In terms of profitability, NXGLW's ROE is -0.63%, compared to IGAP's ROE of +3.93%. Regarding short-term risk, NXGLW is more volatile compared to IGAP. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs DXR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, DXR has a market cap of 44.1M. Regarding current trading prices, NXGLW is priced at $0.25, while DXR trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas DXR's P/E ratio is -101.28. In terms of profitability, NXGLW's ROE is -0.63%, compared to DXR's ROE of +0.02%. Regarding short-term risk, NXGLW is more volatile compared to DXR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs POCI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, POCI has a market cap of 36.1M. Regarding current trading prices, NXGLW is priced at $0.25, while POCI trades at $4.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas POCI's P/E ratio is -5.17. In terms of profitability, NXGLW's ROE is -0.63%, compared to POCI's ROE of -0.54%. Regarding short-term risk, NXGLW is more volatile compared to POCI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NEPH Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, NEPH has a market cap of 35.6M. Regarding current trading prices, NXGLW is priced at $0.25, while NEPH trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas NEPH's P/E ratio is 42.00. In terms of profitability, NXGLW's ROE is -0.63%, compared to NEPH's ROE of +0.09%. Regarding short-term risk, NXGLW is more volatile compared to NEPH. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs SDC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, NXGLW is priced at $0.25, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas SDC's P/E ratio is -0.03. In terms of profitability, NXGLW's ROE is -0.63%, compared to SDC's ROE of -1.96%. Regarding short-term risk, NXGLW is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs IVC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, NXGLW is priced at $0.25, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas IVC's P/E ratio is -0.79. In terms of profitability, NXGLW's ROE is -0.63%, compared to IVC's ROE of -0.46%. Regarding short-term risk, NXGLW is more volatile compared to IVC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs FEMY Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, FEMY has a market cap of 21.8M. Regarding current trading prices, NXGLW is priced at $0.25, while FEMY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas FEMY's P/E ratio is -0.88. In terms of profitability, NXGLW's ROE is -0.63%, compared to FEMY's ROE of -3.92%. Regarding short-term risk, NXGLW is more volatile compared to FEMY. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs WOK Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, WOK has a market cap of 20.4M. Regarding current trading prices, NXGLW is priced at $0.25, while WOK trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas WOK's P/E ratio is -3.07. In terms of profitability, NXGLW's ROE is -0.63%, compared to WOK's ROE of -0.30%. Regarding short-term risk, NXGLW is less volatile compared to WOK. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs RVP Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, RVP has a market cap of 19.9M. Regarding current trading prices, NXGLW is priced at $0.25, while RVP trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas RVP's P/E ratio is -0.89. In terms of profitability, NXGLW's ROE is -0.63%, compared to RVP's ROE of -0.27%. Regarding short-term risk, NXGLW is more volatile compared to RVP. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs HBIO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, HBIO has a market cap of 18.1M. Regarding current trading prices, NXGLW is priced at $0.25, while HBIO trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas HBIO's P/E ratio is -0.31. In terms of profitability, NXGLW's ROE is -0.63%, compared to HBIO's ROE of -1.10%. Regarding short-term risk, NXGLW is less volatile compared to HBIO. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs MHUA Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, MHUA has a market cap of 18.1M. Regarding current trading prices, NXGLW is priced at $0.25, while MHUA trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas MHUA's P/E ratio is 1.43. In terms of profitability, NXGLW's ROE is -0.63%, compared to MHUA's ROE of +0.09%. Regarding short-term risk, NXGLW is less volatile compared to MHUA. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NXGL Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, NXGL has a market cap of 17.6M. Regarding current trading prices, NXGLW is priced at $0.25, while NXGL trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas NXGL's P/E ratio is -5.11. In terms of profitability, NXGLW's ROE is -0.63%, compared to NXGL's ROE of -0.63%. Regarding short-term risk, NXGLW is more volatile compared to NXGL. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs LUCYW Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, LUCYW has a market cap of 13.8M. Regarding current trading prices, NXGLW is priced at $0.25, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas LUCYW's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to LUCYW's ROE of -0.95%. Regarding short-term risk, NXGLW is less volatile compared to LUCYW. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs EKSO Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, EKSO has a market cap of 10.2M. Regarding current trading prices, NXGLW is priced at $0.25, while EKSO trades at $4.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas EKSO's P/E ratio is -0.59. In terms of profitability, NXGLW's ROE is -0.63%, compared to EKSO's ROE of -0.82%. Regarding short-term risk, NXGLW is more volatile compared to EKSO. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs LUCY Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, LUCY has a market cap of 8.9M. Regarding current trading prices, NXGLW is priced at $0.25, while LUCY trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas LUCY's P/E ratio is 0.07. In terms of profitability, NXGLW's ROE is -0.63%, compared to LUCY's ROE of -0.95%. Regarding short-term risk, NXGLW is more volatile compared to LUCY. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs POAI Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, POAI has a market cap of 8.4M. Regarding current trading prices, NXGLW is priced at $0.25, while POAI trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas POAI's P/E ratio is -0.66. In terms of profitability, NXGLW's ROE is -0.63%, compared to POAI's ROE of -5.91%. Regarding short-term risk, NXGLW is more volatile compared to POAI. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs STSS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, STSS has a market cap of 6M. Regarding current trading prices, NXGLW is priced at $0.25, while STSS trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas STSS's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to STSS's ROE of -0.99%. Regarding short-term risk, NXGLW is less volatile compared to STSS. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs NSTG Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, NXGLW is priced at $0.25, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas NSTG's P/E ratio is -0.03. In terms of profitability, NXGLW's ROE is -0.63%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, NXGLW is less volatile compared to NSTG. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs GCTK Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, GCTK has a market cap of 4.1M. Regarding current trading prices, NXGLW is priced at $0.25, while GCTK trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas GCTK's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to GCTK's ROE of +3.93%. Regarding short-term risk, NXGLW is more volatile compared to GCTK. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs GMVD Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, NXGLW is priced at $0.25, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas GMVD's P/E ratio is -0.01. In terms of profitability, NXGLW's ROE is -0.63%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, NXGLW is less volatile compared to GMVD. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs GMVDW Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, NXGLW is priced at $0.25, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas GMVDW's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, NXGLW is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs AVGR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, NXGLW is priced at $0.25, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas AVGR's P/E ratio is -0.05. In terms of profitability, NXGLW's ROE is -0.63%, compared to AVGR's ROE of -54.25%. Regarding short-term risk, NXGLW is less volatile compared to AVGR. This indicates potentially lower risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs IIN Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, IIN has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas IIN's P/E ratio is 226.45. In terms of profitability, NXGLW's ROE is -0.63%, compared to IIN's ROE of -0.00%. Regarding short-term risk, NXGLW is more volatile compared to IIN. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs HRC Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, HRC has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas HRC's P/E ratio is 41.92. In terms of profitability, NXGLW's ROE is -0.63%, compared to HRC's ROE of +0.14%. Regarding short-term risk, NXGLW is more volatile compared to HRC. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs APR Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, APR has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas APR's P/E ratio is 22.59. In terms of profitability, NXGLW's ROE is -0.63%, compared to APR's ROE of +9.81%. Regarding short-term risk, NXGLW is more volatile compared to APR. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs ATRS Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas ATRS's P/E ratio is 14.95. In terms of profitability, NXGLW's ROE is -0.63%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, NXGLW is more volatile compared to ATRS. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.
NXGLW vs LMNX Comparison
NXGLW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NXGLW stands at 25.2M. In comparison, LMNX has a market cap of 0. Regarding current trading prices, NXGLW is priced at $0.25, while LMNX trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NXGLW currently has a P/E ratio of -0.18, whereas LMNX's P/E ratio is N/A. In terms of profitability, NXGLW's ROE is -0.63%, compared to LMNX's ROE of +0.03%. Regarding short-term risk, NXGLW is more volatile compared to LMNX. This indicates potentially higher risk in terms of short-term price fluctuations for NXGLW.